Saxagliptin, an anti-diabetic drug, is indicated for the treatment and management of type-2 diabetes in adults. Saxagliptin can be prescribed either as a monotherapy or as a combined therapy with insulin or sulphonylurea. Saxagliptin should be prescribed as a comprehensive treatment with diet, exercise and lifestyle modifications.
Saxagliptin inhibits enzymatic activity of DPP4 that leads to decreased levels of glucagon, glucagon-dependent insulin, GIP and GLP-1.
After oral administration, the drug achieves Cmax within 2 hours, and the absorption is influenced by high-fat meals. The drug is metabolized via the cytochrome P450 system. Saxagliptin is eliminated via the urine and hepatic pathways. The terminal half-life of Saxagliptin is 2.5-3.1 hours.
No information available
Some of the commonly reported adverse events of Saxagliptin are headache, UTI and URI, ITP, abdominal pain, nausea or vomiting, gastroenteritis and hypoglycemia.
Caution should be exercised while prescribing Saxagliptin to patients with pancreatitis, hypersensitivity to synthetic drugs, angioedema or exfoliative skin reactions. Monitor patients continuously while prescribing Saxagliptin with insulin or sulfonylurea.
No information available
Saxagliptin may interact with quinolone antibiotics, olanzapine, macrolide antibiotics, HIV protease inhibitors, nefazodone, azole anti-fungal drugs and beta-blockers.
Do not consume alcohol while taking Saxagliptin. It can cause serious hypoglycemia.
The recommended adult dosage of Saxagliptin is 2.5-5 mg, once daily.
Saxagliptin can be taken before or after food intake
USFDA pregnancy category B. Saxagliptin may not cause harm to an unborn foetus. Before Saxagliptin treatment, the patient should discuss with the physician, if they are planning for a pregnancy.
Nursing mothers should consult a physician before taking Saxagliptin
Saxagliptin is contraindicated in children.
No information available
No information available
No information available
No information available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.